Ji and Patrick Kennedy at the Gateway Gala for the BioNJ Annual Meeting and Life Science Innovation Celebration in East Brunswick, NJ, 2016

Ji speaks at the New Drug Development Forum in Beijing, China, 2001

Ji receives the Innovation Award at the BioNJ Annual Meeting presented by Debbie Hart, CEO and President of BioNJ, for the development and approval of Praluent® in 2016

Ji with colleagues in Bridgewater, NJ celebrating career achievements, 2019

Ji Zhang

Chief Operating Officer

Dr. Ji Zhang is Chief Operating Officer of ModeX Therapeutics. He was most recently Senior Partner and Senior Vice President of Enterprise R&D Operations for Flagship Pioneering, and previously Senior Vice President, Global Head of Research and Development Operations at Sanofi. An experienced and senior biotech and biopharmaceutical R&D executive with strategic vision and operations leadership in multiple scientific areas, he has a successful track record in building up new capabilities and transforming organizations, delivering multiple innovative medicines with accelerated speed, high quality, strong financial management and flexible business models. Dr. Zhang has demonstrated leadership and strategic foresight in establishing a global operations team in strategic countries, creating strong teams with particular attention to multi-culture development and diverse executive leaders.

Dr. Zhang earned a B.S. and M.S. in mathematics from Peking University and a Ph.D. in statistics from North Carolina State University. He is an elected Fellow of the American Statistical Association, and has published more than 100 peer-reviewed scientific papers and technical reports in clinical development and research methodology areas. He has a passion for public good and social responsibilities, volunteering for and supporting educational and medical research activities and serving on the boards of several not-for-profit organizations.